Avoiding Detrimental Human Immune Response Against Mammalian Extracellular Matrix Implants
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
This review describes the antibodies formed against mammalian extracellular matrix (ECM) implants in humans and proposes methods for avoiding the detrimental effects of these antibodies. There are two types of antibodies against ECM implants: (i) The natural anti-Gal antibody constituting ∼1% of immunoglobulins in humans. This antibody binds to a carbohydrate antigen called the α-gal epitope with the structure Galα1-3Galβ1-4GlcNAc-R. The α-gal epitope is abundant in nonprimate mammals, including on ECM proteins and proteoglycans. Moreover, anti-Gal antibody titers increase within 2-4 weeks by 10- to 100-folds in human recipients of mammalian implants or xenografts expressing α-gal epitopes. (ii) Anti-non gal antibodies formed against ECM peptide sequences differing from those in homologous proteins in humans. Most homologous proteins in mammals contain immunogenic peptides that elicit anti-non gal antibody production when introduced into humans. Formation of anti-non gal antibodies is much slower than that of elicited anti-Gal antibodies. Both anti-Gal and anti-non gal antibodies are detrimental to ECM implant regeneration in humans by binding to the ECM and directing extensive macrophage-mediated degradation of the implant. In addition, antibodies binding to ECM proteins/proteoglycans may hinder stem cells interaction with the ECM, which is required for directing stem cell differentiation. The anti-Gal immunological barrier can be avoided by using mammalian ECM implants lacking α-gal epitopes. Such implants can be engineered by enzymatic destruction of α-gal epitopes with recombinant α-galactosidase. Alternatively, implants may be obtained from α1,3galactosyltransferase knockout donor species that lack α-gal epitopes. Since postimplantation production of anti-non gal antibodies is a slow process, the detrimental effects of these antibodies may be avoided by accelerating stem cells recruitment into implants, thus accelerating the regeneration process. Acceleration of stem cell recruitment may be achieved by introducing α-gal nanoparticles into the implant. α-Gal nanoparticles present multiple α-gal epitopes, which bind anti-Gal and induce recruitment of macrophages by generating complement chemotactic factors. Fc/Fcγ receptor interaction between anti-Gal coating α-gal nanoparticles and recruited macrophages activates the macrophages to secrete "pro-healing" cytokines/growth factors that recruit stem cells. These recruited cells are instructed by the implanted ECM to regenerate the implant before anti-non gal antibodies can reach detrimental titers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An overview of tissue and whole organ decellularization processes
Crapo, P. M., Gilbert, T. W., & Badylak, S. F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.057 · Cited by 3,591
Immune response to biologic scaffold materials
Badylak, S. F., & Gilbert, T. W. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.003 · Cited by 857 · cited 1×
“8–10 Production of both anti-Gal and anti-non gal antibodies cannot be prevented by immunosuppression protocols potent enough to prevent allograft rejection.”
Rates of DNA sequence evolution differ between taxonomic groups.
Britten, R. J. (1986) · Science · doi:10.1126/science.3082006 · Cited by 782 · cited 1×
“These differences are the result of mutations accumulated during the > 75 million years of separate evolution of the various mammalian lineages.(68,69) Collagen is one of the few proteins that have been highly conserved throughout mammalian evolution since most mutations in collagen are lethal.”
Thall, A. D., Malý, P., & Lowe, J. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21437 · Cited by 401
XENOGENEIC EXTRACELLULAR MATRIX GRAFTS ELICIT A TH2-RESTRICTED IMMUNE RESPONSE1
Allman, A. J., McPherson, T. B., Badylak, S. F., Merrill, L. C., Kallakury, B., Sheehan, C., Raeder, R. H., & Metzger, D. W. (2001) · Transplantation · doi:10.1097/00007890-200106150-00024 · Cited by 388
Macrophage complement receptors and pathogen clearance
van Lookeren Campagne, M., Wiesmann, C., & Brown, E. J. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00981.x · Cited by 332 · cited 12×
“(ii) Anti-non gal antibodies binding to immunogenic peptides within the protein portions of the ECM.”
InfluentialZhang, Y., He, Y., Bharadwaj, S., Hammam, N., Carnagey, K., Myers, R., Atala, A., & Van Dyke, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.005 · Cited by 276
Decellularization for whole organ bioengineering
Arenas-Herrera, J. E., Ko, I. K., Atala, A., & Yoo, J. J. (2013) · Biomedical Materials · doi:10.1088/1748-6041/8/1/014106 · Cited by 221
Cited by
Kasravi, M., Ahmadi, A., Babajani, A., Mazloomnejad, R., Hatamnejad, M. R., Shariatzadeh, S., Bahrami, S., & Niknejad, H. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00348-z · Cited by 316
The host response to naturally-derived extracellular matrix biomaterials
Morris, A. H., Stamer, D. K., & Kyriakides, T. R. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.01.002 · Cited by 180
Inflammation in tissue engineering: The Janus between engraftment and rejection
Crupi, A., Costa, A., Tarnok, A., Melzer, S., & Teodori, L. (2015) · European Journal of Immunology · doi:10.1002/eji.201545818 · Cited by 108
Stone, K. R., Walgenbach, A., & Galili, U. (2017) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0332 · Cited by 22
Self-citation
Metadata
- Authors
- Galili, U.
- Venue
- Tissue Engineering Part B: Reviews
- Publisher
- SAGE Publications
- Published
- 2015-04
- Volume
- 21
- Issue
- 2
- Pages
- 231-241
- ISSN
- 1937-3368 (ISSN-L)
- 1937-3376
- OpenAlex
- W1489366589
- Cited by
- 51
- References
- 8
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Avoiding Detrimental Human Immune Response Against Mammalian Extracellular Matrix Implants. https://app.cochat.ai/papers/10.1089/ten.teb.2014.0392
- The paper
- Galili, U. (2015). Avoiding Detrimental Human Immune Response Against Mammalian Extracellular Matrix Implants. Tissue Engineering Part B: Reviews. https://doi.org/10.1089/ten.teb.2014.0392
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.